Other News To Note
Friday, June 22, 2012
Catalyst Pharmaceutical Partners Inc., of Coral Gables, Fla., said it received a Nasdaq letter indicating the firm is not in compliance with the minimum bid price requirement for continued listing. Catalyst has 180 calendar days to regain compliance.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.